⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VALN News
Valneva SE American Depositary Shares
Valneva Provides Update on Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference
globenewswire.com
VALN
Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
globenewswire.com
VALN
Valneva to Further Consolidate its Operations in France
globenewswire.com
VALN
Valneva Announces Positive Final Phase 2 Results for Lyme Disease Vaccine Candidate
globenewswire.com
VALN
PFE
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALN
prnewswire.com
VALN